Context Therapeutics Statistics
NASDAQ: CNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.299-0.0136 (-4.35%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 0.3071 +2.71%
Context Therapeutics by the numbers
Context Therapeutics has a market capitalization of $27.5 million based on 91.88M shares outstanding. With trailing EPS of $-0.48, Context Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.0% below its 50-day average and 80.8% below its 200-day average.
Average daily trading volume is 1.83M shares, or about $545,853 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CNTX valuation vs. peer median
| Metric | CNTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $27.47M | $27.37M | +0% |
| Avg. volume | 1.83M | 351.39K | +420% |
Peer median across 8 companies: IMMP, SHPH, MCRB, ABVC, RNAZ, IGC, MIRA, BYSI.
Valuation
- Market cap
- $27.47M
- EPS (TTM)
- $-0.48
- Shares outstanding
- 91.88M
Price and trading
- Previous close
- 0.3126
- Open
- 0.3109
- Day range
- 0.2954 – 0.3159
- 52-week range
- 0.2954 – 3.62
- 52-week change
- -72.34%
- 50-day moving average
- 0.4272
- Beta
- —
- Volume
- 912.60K
- Average volume
- 1.83M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 27.47M
- Forward Pe
- -0.69
- Eps
- -0.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.62
- Week52 Low
- 0.30
- Avg Volume
- 1.83M
- Shares Outstanding
- 91.88M
- Ma50
- 0.43
- Ma200
- 1.56
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -91.74%
- Pct From52w Low
- 1.22%